Cargando…
Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10
BACKGROUND: Sepsis remains a source of high mortality in hospitalized patients despite proper antibiotic approaches. Encouragingly, mesenchymal stromal cells (MSCs) and their produced extracellular vesicles (EVs) have been shown to elicit anti-inflammatory effects in multiple inflammatory conditions...
Autores principales: | Park, Kyong-Su, Svennerholm, Kristina, Shelke, Ganesh V., Bandeira, Elga, Lässer, Cecilia, Jang, Su Chul, Chandode, Rakesh, Gribonika, Inta, Lötvall, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676541/ https://www.ncbi.nlm.nih.gov/pubmed/31370884 http://dx.doi.org/10.1186/s13287-019-1352-4 |
Ejemplares similares
-
Escherichia coli outer membrane vesicles can contribute to sepsis induced cardiac dysfunction
por: Svennerholm, Kristina, et al.
Publicado: (2017) -
Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy
por: Park, Kyong‐Su, et al.
Publicado: (2021) -
Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles
por: Park, Kyong-Su, et al.
Publicado: (2019) -
Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2
por: Park, Kyong-Su, et al.
Publicado: (2023) -
Effects of mesenchymal stem cell-derived nanovesicles in experimental allergic airway inflammation
por: Bandeira, Elga, et al.
Publicado: (2023)